Global Trade Shift: China's New Export Routes
China's exports surged unexpectedly as companies rushed shipments to beat the expiration of a trade truce with the U.S. This shift is creating investment opportunities in the Southeast Asian and Belt and Road Initiative economies that are facilitating this redirected trade.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Join Nemo FREE today and unlock every stock
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
China's unexpected export surge, driven by companies rushing shipments before U.S. trade agreements expire, signals a major shift in global commerce. This redirection away from direct U.S. channels towards Southeast Asian and Belt and Road economies creates significant investment opportunities in the infrastructure facilitating this new trade flow.
What You Need to Know
This group focuses on companies operating in critical sectors like logistics, freight forwarding, port management, and e-commerce fulfilment. These businesses are positioned to handle increased trade volumes and benefit from new investments in supply chain infrastructure as global trade patterns evolve.
Why These Stocks
Each company was handpicked by professional analysts for their strategic position in capturing value from this supply chain realignment. They're the facilitators of rerouted trade, offering tactical exposure to structural changes in global commerce and potential growth tied to evolving geopolitical dynamics.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+42.44%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 42.44% over the next year.
Stocks Rated Buy by Analysts
13 of 14 assets in this group are rated Buy by professional analysts.
Why You'll Want to Watch These Stocks
Trade Routes Are Shifting
China's 7.2% export surge whilst direct U.S. exports dropped 21.6% signals a massive redirection of global trade flows. Companies facilitating these new routes could see unprecedented demand.
Infrastructure Investment Boom
Southeast Asian and Belt and Road economies are receiving increased investment to handle rerouted trade volumes. The logistics companies managing this transition stand to benefit significantly.
First-Mover Advantage
These handpicked companies are already positioned at the centre of this supply chain realignment. Getting in early could mean capturing value as this structural shift accelerates.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.